Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lonza Set to Enter Probiotic Market - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Lonza Set to Enter Probiotic Market

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Lonza, Basel, Switzerland, has signed an exclusive license agreement with Berlin, Germany-based ORGANOBALANCE for the global development, production and commercialization of products containing a probiotic Lactobacillus strain. Developed by ORGANOBALANCE GmbH via a fermentation process, the probiotic strain acts against Helicobacter pylori (H. pylori). Research shows that H. pylori has been implicated as a common cause of peptic ulcers and gastritis.

Utilizing a unique patent-protected mode of action, Lactobacillus anti-H. pylori binds to H. pylori in the stomach, thus creating large aggregates, which are subsequently flushed out of the stomach and excreted.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters